preclinical validation

Meet DIVERSA at Swiss Biotech Days, Vitafoods Europe & Bioga BioDays 2026 | Book a Partnering Meeting

Meet DIVERSA at Key Biotech & Life Sciences Events – May 2026 May is a key month for innovation and partnering in biotech, nutraceuticals and life sciences. DIVERSA Technologies will be attending three major European events, actively engaging through partnering platforms and 1:1 meetings to [...]

2026-04-06T13:19:01+00:00April 6, 2026|Company news, Events|

Personalized nanomedicine at the bedside: the next frontier in RNA-Nanoparticle Therapies

Discover how lipid nanoparticles (LNPs) are powering a new era of personalized nanomedicine. Nanoparticle delivery systems are making bedside RNA therapies a reality.   A paradigm shift: from mass production to personalized RNA therapies   Imagine a future where life-saving RNA therapies are not manufactured [...]

2025-09-11T07:37:18+00:00September 11, 2025|Blog|

From bench to bedside: accelerating clinical translation with lipid nanoparticles

The journey from scientific discovery to patient benefit is often long and uncertain. But in recent years, lipid nanoparticles (LNPs) have emerged as a key enabler for accelerating the clinical translation of innovative therapies, including mRNA, proteins, peptides, and gene-editing tools. At DIVERSA, we are designing next-generation nanoparticles that [...]

2025-07-22T07:32:28+00:00July 22, 2025|Blog|
Go to Top